186 related articles for article (PubMed ID: 29206496)
41. Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization.
Yousaf AM; Malik UR; Shahzad Y; Mahmood T; Hussain T
J Pharm Anal; 2019 Feb; 9(1):34-39. PubMed ID: 30740255
[TBL] [Abstract][Full Text] [Related]
42. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.
Pina MF; Zhao M; Pinto JF; Sousa JJ; Craig DQ
J Pharm Sci; 2014 Apr; 103(4):1214-23. PubMed ID: 24765654
[TBL] [Abstract][Full Text] [Related]
43. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
[TBL] [Abstract][Full Text] [Related]
44. Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs.
Fael H; Ràfols C; Demirel AL
J Pharm Sci; 2018 Sep; 107(9):2428-2438. PubMed ID: 29859957
[TBL] [Abstract][Full Text] [Related]
45. A novel surface-attached carvedilol solid dispersion with enhanced solubility and dissolution.
Lee SN; Poudel BK; Tran TH; Marasini N; Pradhan R; Lee YI; Lee DW; Woo JS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2013 Jan; 36(1):79-85. PubMed ID: 23328872
[TBL] [Abstract][Full Text] [Related]
46. Development of solid dispersions based on 3- (2,6-difluorobenzyl) -5- (5-bromo-1H-indol-3-ylmethylene) thiazolidine-2,4-dione for schistosomicidal treatment.
Paulino S; Santos L; Rabello M; da Silva P; Oliveira J; Lima MDC; Rocha T; Albuquerque M; Santos V; Alves L; Brayner F; Gomes T; Aires A; Neto PR; Silva R
Exp Parasitol; 2023 May; 248():108455. PubMed ID: 36764643
[TBL] [Abstract][Full Text] [Related]
47. Dissolution rate enhancement of the novel antitumoral beta-lapachone by solvent change precipitation of microparticles.
Cunha-Filho MS; Martínez-Pacheco R; Landín M
Eur J Pharm Biopharm; 2008 Aug; 69(3):871-7. PubMed ID: 18395431
[TBL] [Abstract][Full Text] [Related]
48. Fast-dissolving and high-drug-loaded, Fatty Acid-based self-emulsifying solid dispersions of diacerein.
Aggarwal AK; Singh S
PDA J Pharm Sci Technol; 2012; 66(3):201-13. PubMed ID: 22634586
[TBL] [Abstract][Full Text] [Related]
49. Preparation and characterization of cefuroxime axetil solid dispersions using hydrophilic carriers.
Gorajana A; Rajendran A; Yew LM; Dua K
Int J Pharm Investig; 2015; 5(3):171-8. PubMed ID: 26258059
[TBL] [Abstract][Full Text] [Related]
50. Binary and ternary solid dispersions of an anticancer preclinical lead, IIIM-290: In vitro and in vivo studies.
Kumar V; Mintoo MJ; Mondhe DM; Bharate SB; Vishwakarma RA; Bharate SS
Int J Pharm; 2019 Oct; 570():118683. PubMed ID: 31513869
[TBL] [Abstract][Full Text] [Related]
51. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify.
Wang B; Wang D; Zhao S; Huang X; Zhang J; Lv Y; Liu X; Lv G; Ma X
Eur J Pharm Sci; 2017 Jan; 96():45-52. PubMed ID: 27568852
[TBL] [Abstract][Full Text] [Related]
52. Pioglitazone solid dispersion system prepared by spray drying method: in vitro and in vivo evaluation.
Pokharkar V; Kutwal M; Mandpe L
PDA J Pharm Sci Technol; 2013; 67(1):23-34. PubMed ID: 23385561
[TBL] [Abstract][Full Text] [Related]
53. Cefdinir Solid Dispersion Composed of Hydrophilic Polymers with Enhanced Solubility, Dissolution, and Bioavailability in Rats.
Cho HJ; Jee JP; Kang JY; Shin DY; Choi HG; Maeng HJ; Cho KH
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208830
[TBL] [Abstract][Full Text] [Related]
54. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
55. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of dissolution profile by solid dispersion (kneading) technique.
Modi A; Tayade P
AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249
[TBL] [Abstract][Full Text] [Related]
57. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
58. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I.
Papadimitriou SA; Barmpalexis P; Karavas E; Bikiaris DN
Eur J Pharm Biopharm; 2012 Sep; 82(1):175-86. PubMed ID: 22732266
[TBL] [Abstract][Full Text] [Related]
59. [Preparation and dissolution in vitro of esomeprazole zinc solid dispersion].
Xie P; Xie YM; Song H; Song X; Zuo YJ; Qiu Y; Tang XH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):648-50. PubMed ID: 18798516
[TBL] [Abstract][Full Text] [Related]
60. Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones.
Zhai X; Li C; Lenon GB; Xue CCL; Li W
Asian J Pharm Sci; 2017 Jan; 12(1):85-97. PubMed ID: 32104317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
